A Secondary Analysis of Radiotherapy Oncology Group (RTOG/NRG) Trials 9202, 9413, and 9910: Unknown Causes of Death and Their Impact on Prostate Cancer Specific Mortality Estimates

被引:0
|
作者
Lee, J. Y. [1 ]
Wu, X. [2 ]
Wang, M. [3 ]
Kishan, A. U. [4 ]
Jia, A. Y. [5 ]
Spratt, D. E. [6 ]
Sandler, H. M. [7 ]
Efstathiou, J. A. [8 ]
Zaorsky, N. G. [9 ]
机构
[1] Univ Hosp, Cleveland Med Ctr, Cleveland, OH USA
[2] Penn State Coll Med, Hershey, PA USA
[3] Case Western Reserve Univ, Dept Populat & Quantitat Hlth Sci, Cleveland, OH USA
[4] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA
[5] Weill Cornell Med Coll New York Presbyterian Hosp, New York, NY USA
[6] Case Western, Cleveland, OH USA
[7] Cedars Sinai Med Ctr, Los Angeles, CA USA
[8] Harvard Med Sch, Dept Radiat Oncol, Boston, MA USA
[9] Case Western Reserve Univ, Univ Hosp, Seidman Canc Ctr, Cleveland, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3215
引用
收藏
页码:E550 / E551
页数:2
相关论文
共 8 条
  • [1] Biopsy-based basal-luminal subtyping classifier in high-risk prostate cancer: Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 randomized phase III trials
    Nguyen, P.
    Liu, V.
    Proudfoot, J. A.
    Davicioni, E.
    Liu, Y.
    Dal Pra, A.
    Spratt, D. E.
    Sandler, H. M.
    Efstathiou, J. A.
    Lawton, C.
    Simko, J. P.
    Rosenthal, S.
    Zeitzer, K.
    Mendez, L.
    Hartford, A.
    Hall, W.
    Desai, A.
    Pugh, S.
    Tran, P. T.
    Feng, F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1172 - S1173
  • [2] Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
    Nguyen, Paul L.
    Huang, Huei-Chung
    Spratt, Daniel E.
    Davicioni, Elai
    Sandler, Howard M.
    Shipley, William U.
    Efstathiou, Jason A.
    Simko, Jeffry P.
    Pollack, Alan
    Dicker, Adam P.
    Roach III, Mack
    Rosenthal, Seth A.
    Zeitzer, Kenneth L.
    Mendez, Lucas C.
    Hartford, Alan C.
    Hall, William A.
    Desai, Anand B.
    Rabinovitch, Rachel A.
    Peters, Christopher A.
    Rodgers, Joseph P.
    Tran, Phuoc
    Feng, Felix Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 521 - 529
  • [3] Validation of a 22-gene Genomic Classifier in the NRG Oncology/RTOG 9202, 9413 and 9902 Phase III Randomized Trials: A Biopsy-Based Individual Patient Meta-Analysis in High-Risk Prostate Cancer
    Nguyen, P. L.
    Huang, H. C.
    Davicioni, E.
    Sandler, H. M.
    Shipley, W. U.
    Efstathiou, J. A.
    Simko, J.
    Pollack, A.
    Dicker, A. P.
    Roach, M.
    Rosenthal, S. A.
    Morginstin, M.
    Mendez, L.
    Hartford, A. C.
    Hall, W. A.
    Desai, A. B.
    Rabinovitch, R.
    Peters, C. A.
    Rodgers, J.
    Feng, F. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S50 - S50
  • [4] Effect of Long-Term Hormonal Therapy (vs Short-Term Hormonal Therapy): A Secondary Analysis of Intermediate-Risk Prostate Cancer Patients Treated on NRG Oncology RTOG 9202
    Mirhadi, Amin J.
    Zhang, Qiang
    Hanks, Gerald E.
    Lepor, Herbert
    Grignon, David J.
    Peters, Christopher A.
    Rosenthal, Seth A.
    Zeitzer, Kenneth
    Radwan, John S.
    Lawton, Colleen
    Parliament, Matthew B.
    Reznik, Robert S.
    Sandler, Howard M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 511 - 515
  • [5] Nadir Prostate-Specific Antigen After Neoadjuvant Androgen Suppression (AS) in Prostate Cancer Patients Receiving Short-term AS and Radiation Therapy: Pooled Analysis of Four NRG Oncology/RTOG Randomized Clinical Trials
    Hallemeier, C. L.
    Zhang, P.
    Pisansky, T. M.
    Hanks, G. E.
    McGowan, D. G.
    Roach, M., III
    Zeitzer, K. L.
    Firat, S.
    Husain, S. M.
    D'Souza, D. P.
    Souhami, L.
    Parliament, M. B.
    Rosenthal, S. A.
    Lukka, H.
    Rotman, M. Z.
    Horwitz, E. M.
    Miles, E.
    Sandler, H. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S46 - S46
  • [6] Conditional Risks of Biochemical Failure and Prostate Cancer-Specific Death in Patients Undergoing External Beam Radiotherapy A Secondary Analysis of 2 Randomized Clinical Trials
    Alexander, Gregory S.
    Krc, Rebecca F.
    Assif, James W.
    Sun, Kai
    Molitoris, Jason K.
    Tran, Phuoc
    Rana, Zaker
    Bentzen, Soren M.
    Mishra, Mark V.
    JAMA NETWORK OPEN, 2023, 6 (09)
  • [7] OLDER AGE PREDICTS DECREASED METASTASIS AND PROSTATE CANCER-SPECIFIC DEATH FOR MEN TREATED WITH RADIATION THERAPY: META-ANALYSIS OF RADIATION THERAPY ONCOLOGY GROUP TRIALS
    Hamstra, Daniel A.
    Bae, Kyounghwa
    Pilepich, Miljenko V.
    Hanks, Gerald E.
    Grignon, David J.
    McGowan, David G.
    Roach, Mack
    Lawton, Colleen
    Lee, R. Jeffrey
    Sandler, Howard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1293 - 1301
  • [8] Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials
    Hallemeier, Christopher L.
    Zhang, Peixin
    Pisansky, Thomas M.
    Hanks, Gerald E.
    McGowan, David G.
    Roach, Mack, III
    Zeitzer, Kenneth L.
    Firat, Selim Y.
    Husain, Siraj M.
    D'Souza, David P.
    Souhami, Luis
    Parliament, Matthew B.
    Rosenthal, Seth A.
    Lukka, Himanshu R.
    Rotman, Marvin
    Horwitz, Eric M.
    Miles, Edward F.
    Paulus, Rebecca
    Sandler, Howard M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1057 - 1065